Polar Asset Management Partners Inc. Novavax Inc Transaction History

Polar Asset Management Partners Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$36.28 - $75.29 $473,816 - $983,287	13,060 New	13,060 $672,000
Q1 2022 May 16, 2022	SELL	$69.73 - $142.9 $716,406 - $1.47 Million	-10,274 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$134.56 - $217.97 $1.38 Million - $2.24 Million	10,274 New	10,274 $1.47 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $630M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Polar Asset Management Partners Inc., based on Form 13F filings with the SEC.

Stay updated on Polar Asset Management Partners Inc. with notifications on news.